Hot Pursuit     13-Dec-24
Biocon Ltd down for fifth straight session
Biocon Ltd is quoting at Rs 353.2, down 0.98% on the day as on 13:19 IST on the NSE. The stock jumped 42.39% in last one year as compared to a 16.17% rally in NIFTY and a 36.71% spurt in the Nifty Pharma index.

Biocon Ltd is down for a fifth straight session today. The stock is quoting at Rs 353.2, down 0.98% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.24% on the day, quoting at 24608.35. The Sensex is at 81455.03, up 0.2%.Biocon Ltd has added around 5.18% in last one month.Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has increased around 1.53% in last one month and is currently quoting at 22229.3, down 0.65% on the day. The volume in the stock stood at 19.86 lakh shares today, compared to the daily average of 30.53 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 354.55, down 0.89% on the day. Biocon Ltd jumped 42.39% in last one year as compared to a 16.17% rally in NIFTY and a 36.71% spurt in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending September 24.

Previous News
  Biocon jumps as Bengaluru unit gets VAI status from USFDA
 ( Hot Pursuit - 24-Dec-24   15:42 )
  Biocon Ltd spurts 1.41%, up for third straight session
 ( Hot Pursuit - 15-Oct-24   13:05 )
  Biocon’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 15-Jun-24   16:32 )
  Biocon to conduct board meeting
 ( Corporate News - 18-Jul-24   10:37 )
  Biocon, Zentiva get approval for diabetes tratement drug Liraglutide for EU region
 ( Hot Pursuit - 24-Dec-24   09:37 )
  Indices trade with decent gains; realty shares rallied for 5th day
 ( Market Commentary - Mid-Session 17-May-24   12:40 )
  Biocon and Zentiva receive Decentralized Procedure approval for Liraglutide
 ( Corporate News - 24-Dec-24   09:27 )
  Biocon AGM scheduled
 ( Corporate News - 17-May-24   13:47 )
  Biocon Ltd spurts 1.11%, gains for five straight sessions
 ( Hot Pursuit - 24-Aug-23   13:01 )
  Biocon edges higher after obtaining UK MHRA nod for diabetes drug Liraglutide
 ( Hot Pursuit - 28-Mar-24   10:06 )
  Biocon features in S&P's Sustainability Yearbook 2024
 ( Corporate News - 20-Feb-24   12:28 )
Other Stories
  Yes Bank Q3 PAT soars 165% YoY to Rs 612 cr
  25-Jan-25   16:32
  Aditya Birla Real Estate partners with Mitsubishi for their residential project in Bengaluru
  25-Jan-25   15:36
  ICICI Bank Q3 PAT grows 15% YoY to Rs 11,792 crore
  25-Jan-25   15:31
  Sharda Cropchem posts PAT of Rs 31 crore in Q3; records volume growth of 49%
  25-Jan-25   14:20
  LMW posts nearly 81% fall in Q3 PAT to Rs 19 crore
  25-Jan-25   13:21
  DLF PAT jumps 61% YoY to Rs 1,059 crore in Q3 FY25
  25-Jan-25   13:18
  Aditya Birla Money Q3 PAT climbs 44% YoY to Rs 22 cr
  25-Jan-25   11:28
  Interglobe Aviation Q3 PAT drops 18% YoY to Rs 2,449 cr
  25-Jan-25   11:22
  Bank of India Q3 PAT climbs 35% YoY to Rs 2512 cr
  25-Jan-25   09:01
  JSW Steel Q3 PAT tumbles 71% YoY to Rs 719 cr
  24-Jan-25   17:43
Back Top